Cargando…

Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma: A Study in Primary Care

BACKGROUND AND OBJECTIVE: Inhaled corticosteroids (ICS) for COPD has been much debated. Our aim was to identify characteristics associated with prescribing ICS for patients with COPD alone compared to those with concomitant asthma in general practice. PATIENTS AND METHODS: Participating general prac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Savran, Osman, Godtfredsen, Nina Skavlan, Sørensen, Torben, Jensen, Christian, Ulrik, Charlotte Suppli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196437/ https://www.ncbi.nlm.nih.gov/pubmed/32425518 http://dx.doi.org/10.2147/COPD.S241561

Ejemplares similares

COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines?
por: Savran, Osman, et al.
Publicado: (2019)

COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
por: Savran, Osman, et al.
Publicado: (2021)

Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis
por: Savran, Osman, et al.
Publicado: (2023)

ICS and COPD: Time to clear the air
por: Ford, Paul A, et al.
Publicado: (2009)

Biomarker-guided withdrawal of inhaled corticosteroids in asthma patients with a non-T2 inflammatory phenotype – a randomized controlled trial study protocol
por: Mosbech, Christiane Hammershaimb, et al.
Publicado: (2023)

The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients
por: Jordan, Alexander, et al.
Publicado: (2021)

Clinical characteristics of the asthma–COPD overlap syndrome – a systematic review
por: Nielsen, Mia, et al.
Publicado: (2015)

Oral prednisolone for 4 days does not increase exercise tolerance in men with COPD
por: Karlsson, SL, et al.
Publicado: (2017)

Sleep Quality and Self-Reported Symptoms of Anxiety and Depression Are Associated with Physical Activity in Patients with Severe COPD
por: Neale, Christopher D., et al.
Publicado: (2022)

Identifying possible asthma–COPD overlap syndrome in patients with a new diagnosis of COPD in primary care
por: Baarnes, Camilla Boslev, et al.
Publicado: (2017)

Efficacy of ICS versus Non-ICS Combination Therapy in COPD: A Meta-Analysis of Randomised Controlled Trials
por: Ding, Yanling, et al.
Publicado: (2022)

Inspiratory muscle strength and walking capacity in patients with COPD
por: Kofod, Linette Marie, et al.
Publicado: (2019)

Pulmonary telerehabilitation vs. conventional pulmonary rehabilitation – a secondary responder analysis
por: Hansen, Henrik, et al.
Publicado: (2023)

Meta-analysis of routine blood tests as predictors of mortality in COPD
por: Lomholt, Frederikke K., et al.
Publicado: (2014)

Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?
por: Oh, Yeon-Mok
Publicado: (2017)

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
por: Vanfleteren, Lowie, et al.
Publicado: (2018)

Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
por: Vanfleteren, Lowie E.G.W., et al.
Publicado: (2019)

Predictors of ICS/LABA prescribing in COPD patients: a study from general practice
por: Drivenes, Elin, et al.
Publicado: (2014)

Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
por: Suppli Ulrik, Charlotte
Publicado: (2012)

Association between ICS use and risk of hyperglycemia in COPD patients: systematic review and meta-analysis
por: Pu, Xiaofeng, et al.
Publicado: (2021)

Suboptimally controlled asthma in patients treated with inhaled ICS/LABA: prevalence, risk factors, and outcomes
por: Zhang, Shiyuan, et al.
Publicado: (2023)

Magnesium sulfate treatment for acute severe asthma in adults—a systematic review and meta-analysis
por: Rovsing, Alma Holm, et al.
Publicado: (2023)

Incidence and long-term outcome of severe asthma–COPD overlap compared to asthma and COPD alone: a 35-year prospective study of 57,053 middle-aged adults
por: Baarnes, Camilla Boslev, et al.
Publicado: (2017)

Relationship between early life asthma and chronic airway disease in adult life – in search for disease trajectories over the life span- the RELATE study based on the Kongsberg cohort
por: Savran, Osman, et al.
Publicado: (2023)

EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
por: Buhl, Roland, et al.
Publicado: (2023)

Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma
por: Bonnesen, Barbara, et al.
Publicado: (2022)

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
por: Hizawa, Nobuyuki
Publicado: (2015)

Low-dose theophylline in addition to ICS therapy in COPD patients: A systematic review and meta-analysis
por: Shuai, Tiankui, et al.
Publicado: (2021)

Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021)

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device
por: Tashkin, Donald P., et al.
Publicado: (2021)

A COPD-like model of viral exacerbation: synergistic effects with smoke and poly I:C
por: Schlerman, F, et al.
Publicado: (2013)

Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?
por: Tariq, Syed Mohammad, et al.
Publicado: (2017)

Early life insults as determinants of chronic obstructive pulmonary disease in adult life
por: Savran, Osman, et al.
Publicado: (2018)

Determinants of incident asthma–COPD overlap: a prospective study of 55,110 middle-aged adults
por: Baarnes, Camilla Boslev, et al.
Publicado: (2018)

Health characteristics of patients with asthma, COPD and asthma–COPD overlap in the NHANES database
por: Llanos, Jean-Pierre, et al.
Publicado: (2018)

Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study
por: Price, David B., et al.
Publicado: (2016)

And Then There Were Three: Time to Move Onward in COPD Drug Development Beyond LAMA/LABA/ICS at Last?
por: Beeh, Kai M.
Publicado: (2018)

Treatment Response Biomarkers in Asthma and COPD
por: Meteran, Howraman, et al.
Publicado: (2021)

IC Reference
por: Dolmazon, Emeline
Publicado: (2019)

Day-time variation of serum periostin in asthmatic adults treated with ICS/LABA and adults without asthma
por: Caswell-Smith, Rachel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_efv9cqb6ui1qm0c0dr6d3ujdoe